|
|
Volumn 375, Issue 19, 2016, Pages 1834-1844
|
|
Semaglutide and cardiovascular outcomes in patients with type 2 diabetes
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PLACEBO;
SEMAGLUTIDE;
GLUCAGON LIKE PEPTIDE;
GLUCAGON LIKE PEPTIDE 1;
GLYCOSYLATED HEMOGLOBIN;
ACUTE CHOLECYSTITIS;
ACUTE KIDNEY FAILURE;
ACUTE PANCREATITIS;
ADULT;
AGED;
ALLERGIC REACTION;
ARTICLE;
ATRIAL FIBRILLATION;
BLINDNESS;
BODY WEIGHT;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CAUSE OF DEATH;
CEREBROVASCULAR ACCIDENT;
CHOLELITHIASIS;
CHRONIC KIDNEY DISEASE;
CONTROLLED STUDY;
DIABETIC RETINOPATHY;
DIARRHEA;
DISEASE COURSE;
DISEASE DURATION;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
GASTROINTESTINAL SYMPTOM;
GLYCEMIC CONTROL;
HEART DEATH;
HEART INFARCTION;
HUMAN;
HYPOGLYCEMIA;
INJECTION SITE REACTION;
LASER COAGULATION;
MAJOR CLINICAL STUDY;
MALE;
MALIGNANT NEOPLASTIC DISEASE;
NAUSEA;
NEOPLASM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OUTCOME ASSESSMENT;
PANCREAS CANCER;
PRECANCER;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
VITREOUS HEMORRHAGE;
VOMITING;
ANALOGS AND DERIVATIVES;
BLOOD;
CARDIOVASCULAR DISEASES;
CHEMICALLY INDUCED;
CLINICAL TRIAL;
DIABETES MELLITUS, TYPE 2;
DIABETIC NEPHROPATHIES;
GASTROINTESTINAL DISEASE;
KAPLAN MEIER METHOD;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
AGED;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
DIABETIC NEPHROPATHIES;
DIABETIC RETINOPATHY;
FEMALE;
GASTROINTESTINAL DISEASES;
GLUCAGON-LIKE PEPTIDE 1;
GLUCAGON-LIKE PEPTIDES;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
KAPLAN-MEIER ESTIMATE;
MALE;
MIDDLE AGED;
|
|
EID: 84994813253
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMoa1607141 Document Type: Article |
|
Times cited : (3983)
|
|
References (10)
|
